WeVote
Log In

Bill

Bill

SB 226

AN ACT TO AMEND TITLE 16 OF THE DELAWARE CODE RELATING TO MEDICAL MARIJUANA.

153rd General Assembly (2025-2026) Introduced by Russ Huxtable and 12 co-sponsors

SB 226 amends Delaware medical marijuana law, though specific provisions require committee review to clarify patient access, provider roles, or regulatory changes.

Passed By House. Votes: 38 YES 3 ABSENT
0
WeVote Research Nonpartisan
Bill Summary · SB 226

Legislative bill overview

SB 226 proposes amendments to Delaware's medical marijuana statutes under Title 16 of the Delaware Code. The bill was recently introduced and assigned to the Health & Social Services Committee, but specific provisions are not yet publicly detailed in available records.

Why is this important

Medical marijuana policy affects patient access to alternative treatments, healthcare provider responsibilities, regulatory frameworks, and tax revenue generation. Changes to Delaware's existing medical cannabis program could impact thousands of patients currently enrolled and the state's emerging cannabis industry.

Potential points of contention

  • Program expansion vs. fiscal concerns – Whether to expand patient eligibility, dispensary locations, or product types may conflict with budget constraints or regulatory capacity
  • Healthcare provider involvement – Debates likely exist over which physicians can recommend cannabis, documentation requirements, and liability protections
  • Regulatory oversight and enforcement – Balancing patient access with preventing diversion to non-medical use and ensuring product safety standards

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.